Dyslipidaemia has a prominent role in the onset of notorious atherosclerosis, a disease of
medium to large arteries. Atherosclerosis is the prime root of cardiovascular events …

Mycobacterium tuberculosis (Mtb) causes the human disease tuberculosis (TB) and remains
the top global infectious pandemic after coronavirus disease 2019 (COVID-19). Furthermore …

Objective: To investigate the process by which quercetin suppresses atherosclerosis by
upregulating MST1-mediated autophagy in RAW264. 7 macrophages. Methods: An in vitro …

Current pharmacological treatments of atherosclerosis often target either cholesterol control
or inflammation management, to inhibit atherosclerotic progression, but cannot lead to direct …

The pseudokinase TRIB1 controls cell function in a range of contexts, by regulating MAP
kinase activation and mediating protein degradation via the COP1 ubiquitin ligase. TRIB1 …

Herein, a 1, 2, 3-triazole derivative (CBT), synthesized using the Copper (I) catalyzed Alkyne
Azide Cycloaddition (CuAAC) procedure, based on a chalcone skeleton has been reported …

The liver is the site of first pass metabolism, detoxifying and metabolizing blood arriving from
the hepatic portal vein and hepatic artery. It is made up of multiple cell types, including …

Endothelial dysfunction (ED) is a hallmark of atherosclerosis and is influenced by well-
defined risk factors, including hypoxia, dyslipidemia, inflammation, and oscillatory flow …

Adsorption of low-density lipoprotein from plasma is vital for the treatment of dyslipidemia.
Appropriate adsorbent material for efficient and selective adsorption of low-density …

Prostate cancer is the most frequent malignancy in European men and the second
worldwide. One of the major oncogenic events in this disease includes amplification of the …